Publications

Joint associations of device-measured physical activity and sleep duration with incident major adverse cardiovascular events: prospective analysis of the UK Biobank

Brocklebank L. et al, (2025)

Active Monitoring for AtriaL FIbrillation (AMALFI): rationale, protocol, and pilot for a pragmatic, randomized, controlled trial of remote screening for asymptomatic atrial fibrillation.

Wijesurendra R. et al, (2025), American heart journal

Molnupiravir or nirmatrelvir-ritonavir plus usual care versus usual care alone in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial.

RECOVERY Collaborative Group None., (2025), The Lancet. Infectious diseases

Predictive performance of wearable sensors for mortality risk in older adults: a model development and validation study

Harper C. et al, (2025)

Association of Daily Steps with Incident Non-Alcoholic Fatty Liver Disease: Evidence from the UK Biobank Cohort.

Fulda ES. et al, (2025), Medicine and science in sports and exercise

Higher dose corticosteroids in hospitalised COVID-19 patients requiring ventilatory support (RECOVERY): a randomised, controlled, open-label, platform trial.

RECOVERY Collaborative Group None., (2025), EClinicalMedicine, 81

Clinical trial results in context: comparison of baseline characteristics and outcomes of 38,510 RECOVERY trial participants versus a reference population of 346,271 people hospitalised with COVID-19 in England.

Pessoa-Amorim G. et al, (2024), Trials, 25

Association of daily steps with incident non-alcoholic fatty liver disease: Evidence from the UK Biobank cohort

Fulda ES. et al, (2024)

Effects of statin therapy on diagnoses of new-onset diabetes and worsening glycaemia in large-scale randomised blinded statin trials: an individual participant data meta-analysis.

Cholesterol Treatment Trialists’ (CTT) Collaboration. Electronic address: ctt@ndph.ox.ac.uk None. and Cholesterol Treatment Trialists’ (CTT) Collaboration None., (2024), The lancet. Diabetes & endocrinology, 12, 306 - 319

Getting our ducks in a row: The need for data utility comparisons of healthcare systems data for clinical trials.

Sydes MR. et al, (2024), Contemporary clinical trials

Immunomodulatory therapy in children with paediatric inflammatory multisystem syndrome temporally associated with SARS-CoV-2 (PIMS-TS, MIS-C; RECOVERY): a randomised, controlled, open-label, platform trial.

RECOVERY Collaborative Group None., (2024), The Lancet. Child & adolescent health, 8, 190 - 200

Daily steps are a predictor of, but perhaps not a modifiable risk factor for Parkinson’s Disease: findings from the UK Biobank

Acquah A. et al, (2024)

Empagliflozin in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial.

RECOVERY Collaborative Group None., (2023), The lancet. Diabetes & endocrinology, 11, 905 - 914

Convalescent plasma in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial

The RECOVERY Collaborative Group None. et al, (2021)

Cookies on this website

Publications